Analysts at Zacks downgraded shares of Regado Biosciences, Inc. (NASDAQ:RGDO) from an “outperform” rating to a “neutral” rating and set a $1.40 price target on the stock in a research note on Monday, February 23rd. On Monday shares of Regado Biosciences, Inc. (NASDAQ:RGDO) closed at $1.20.
Delta Air Lines, Inc. (NYSE:DAL) is challenging the Obama administration’s decision to bless the export of a processed ultralight crude known as condensate following “secret meetings” with oil companies. Monroe Energy, Delta’s refining subsidiary, made the move in a formal petition filed with the Commerce Department nearly a year after its Bureau of Industry and Security first told two companies they were allowed to export the substance. On Monday shares of Delta Air Lines, Inc. (NYSE:DAL) closed at $45.39. Company’s sales growth for last 5 years was 7.50% and EPS growth for next 5 years is recorded as 19.92%.
Cisco Systems, Inc. (NASDAQ:CSCO) Monday said Bangkok Airways, Thailand’s privately-owned regional airline, has implemented Cisco technology and solutions to help them optimize their business. On Monday shares of Cisco Systems, Inc. (NASDAQ:CSCO) closed at $30.19. Company’s sales growth for last 5 years was 5.50% and EPS growth for next 5 years is recorded as 7.70%.
On 27 February 2015, Infonetics Research, now part of IHS Inc. (NYSE:IHS), has reported that the global service provider voice over IP (VoIP) and IP multimedia subsystem (IMS) equipment market grew 12 percent in 2014, to $4.2 billion, as operators continue to transform their networks to be simpler, more cost effective, and able to offer next gen voice services, chiefly voice over LTE (VoLTE). IHS Inc. (NYSE:IHS) has 1.00% insider ownership while its institutional ownership stands at 99.00%. In last trading activity company’s stock closed at $117.94.
Cytori Therapeutics, Inc. (NASDAQ:CYTX) on February 26, 2015, reported that it received approval from FDA to expand the number of Scleroderma clinical trial sites from 12 to 20 centers in the United States. On last trading day Cytori Therapeutics, Inc. (NASDAQ:CYTX) remains unchanged to close at $1.12. Its volatility for the week is 28.59% while volatility for the month is 13.62%. CYTX’s sales growth for past 5 years was 12.10% and its EPS growth for past 5 years was 19.00%. Cytori Therapeutics, Inc. (NASDAQ:CYTX) monthly performance is 138.30%.